Your Article Summary
MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
Medimmune, 06/30/09
MedImmune continues to advance its commitment to pediatric research with announcement of the first observational prospective study designed to assess the burden of respiratory syncytial virus among preterm infants 32-to-35 weeks gestational age in outpatient settings during their first year of life.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
AstraZeneca and the University of Virginia sign strategic research collaboration to develop novel treatments for cardiovascular disease
AstraZeneca, 12/16/09
Sanofi Pasteur expands study of vaccine against Clostridium difficile into the U.S.
Sanofi-aventis, 12/16/09
Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study
Amylin Pharmaceuticals, 12/16/09
Article Search
Sponsor


See Latest Articles


